BONE MARROW OSTEOPONTIN AS A PROGNOSTIC FACTOR IN MYELODYSPLASTIC SYNDROME

被引：0

作者：

Kim, S. ^{[1
]}

Ji, Y. S. ^{[1
]}

Yun, J. ^{[1
]}

Kim, H. J. ^{[1
,2
]}

Kim, K. H. ^{[3
]}

Kim, H. J. ^{[1
,2
]}

Lee, S. C. ^{[2
]}

Bae, S. B. ^{[2
]}

Kim, C. K. ^{[1
]}

Lee, N. S. ^{[3
]}

Lee, K. T. ^{[2
]}

Park, S. K. ^{[1
]}

Won, J. H. ^{[3
]}

Hong, D. S. ^{[1
]}

机构：

[1] Soonchunhyang Univ Hosp, Div Hematol & Oncol, Bucheon, South Korea

[2] Soonchunhyang Univ Hosp, Div Hematol & Oncol, Cheonan, South Korea

[3] Soonchunhyang Univ Hosp, Div Hematol & Oncol, Seoul, South Korea

来源：

HAEMATOLOGICA | 2015年 / 100卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

PB1828

引用

页码：723 / 723

页数：1

共 50 条

[21] Bone marrow transplantation for myelodysplastic syndrome – who? when? and which? [J].

S Luger ;

N Sacks .

Bone Marrow Transplantation, 2002, 30 :199-206

[22] DasatinibGelatinous bone marrow transformation and myelodysplastic syndrome: case report [J].

Reactions Weekly, 2019, 1749 (1) :163-163

[23] Bone marrow transplantation for myelodysplastic syndrome - who? when? and which? [J].

Luger, S ;

Sacks, N .

BONE MARROW TRANSPLANTATION, 2002, 30 (04) :199-206

[24] Unrelated Donor Bone Marrow Transplantation for Myelodysplastic Syndrome in Children [J].

Woodard, Paul ;

Carpenter, Paul A. ;

Davies, Stella M. ;

Gross, Thomas G. ;

He, Wensheng ;

Zhang, Mei-Jie ;

Horn, Biljana N. ;

Margolis, David A. ;

Perentesis, John P. ;

Sanders, Jean E. ;

Schultz, Kirk R. ;

Seber, Adriana ;

Woods, William G. ;

Eapen, Mary .

BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2011, 17 (05) :723-728

[25] GELATINOUS TRANSFORMATION OF BONE MARROW: A RARE PRESENTATION OF MYELODYSPLASTIC SYNDROME [J].

Hussain, S. ;

Koshy, N. V. ;

Dowden, K. .

JOURNAL OF INVESTIGATIVE MEDICINE, 2009, 57 (04) :615-616

[26] BONE-MARROW TRANSPLANTATION FOR MYELODYSPLASTIC SYNDROME AND SECONDARY LEUKEMIAS [J].

DEWITTE, T ;

GRATWOHL, A .

BRITISH JOURNAL OF HAEMATOLOGY, 1993, 84 (03) :361-364

[27] Vascular endothelial growth factor overexpression in myelodysplastic syndrome bone marrow cells: biological and clinical implications [J].

Invernizzi, Rosangela ;

Travaglino, Erica ;

Della Porta, Matteo Giovanni ;

Malcovati, Luca ;

Galli, Anna ;

Bastia, Raffaella ;

Ciola, Mariella ;

Ambaglio, Ilaria ;

Boveri, Emanuela ;

Rosti, Vittorio ;

Cazzola, Mario .

LEUKEMIA & LYMPHOMA, 2017, 58 (07) :1711-1720

[28] BCL2L10 positive cells in bone marrow are an independent prognostic factor of azacitidine outcome in myelodysplastic syndrome and acute myeloid leukemia [J].

Vidal, Valerie ;

Robert, Guillaume ;

Goursaud, Laure ;

Durand, Laetitia ;

Ginet, Clemence ;

Karsenti, Jean Michel ;

Luciano, Frederic ;

Gastaud, Lauris ;

Garnier, Georges ;

Braun, Thorsten ;

Hirsch, Pierre ;

Raffoux, Emmanuel ;

Nloga, Anne Marie ;

Padua, Rose Ann ;

Dombret, Herve ;

Rohrlich, Pierre ;

Ades, Lionel ;

Chomienne, Christine ;

Auberger, Patrick ;

Fenaux, Pierre ;

Cluzeau, Thomas .

ONCOTARGET, 2017, 8 (29) :47103-47109

[29] ALLOGENEIC MARROW TRANSPLANTATION FOR MYELODYSPLASTIC SYNDROME COMPLICATING AUTOLOGOUS BONE-MARROW TRANSPLANTATION [J].

BASHIR, S ;

COOK, P ;

KATZ, M ;

MITTELMAN, A ;

AHMED, T .

CANCER INVESTIGATION, 1994, 12 (05) :484-487

[30] PCNA/Cyclin: A diagnostic and prognostic factor for myelodysplastic syndrome patients [J].

Bourantas, K ;

Ioachim, E ;

Demou, A ;

Tsiara, S ;

Agnantis, NJ .

JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 1996, 15 (02) :191-195

← 1 2 3 4 5 →